1 / 7

Global Vitiligo Market Forecast

Access full Research: <br>https://www.renub.com/global-vitiligo-market-p.php<br><br>Vitiligo is a long-term skin disease in which patches of the skin lose their color. The skin patches affected by the disease Vitiligo become white. This happens because melanocytes within the skin die off. The skin pigmentation, melanin, due to which skin has its color, protection from sun UV rays this all happens because of melanocytes cells. Growing per capita healthcare expenditure, improving healthcare infrastructure in developing countries, growing diseases awareness and expected approval of Vitiligo drugs are some of the driving force for the growth of this market. However, shortage of dermatologists and available treatments having longer duration of times are major challenges for the growth of this market. According to Renub Research global Vitiligo market will be US$ 2.4 Billion by the year 2024. <br><br>Vitiligo disease prevalence varies between race, regions and countries. It is expected that overall prevalence fall between 1-2 percent of the total population. Although Vitiligo disease can arise at any age, it mostly occurs to young and middle age people. At present globally over 21 Million people has suffered from this diseases. <br> <br>Request a free sample copy of the report: https://www.renub.com/contactus.php<br><br>Renub Research report titled “Global Vitiligo Market, Patients By Countries (United States, United Kingdom, France, Germany, Italy, India, China, Japan), Drugs (ARN-4079, ATI-502, AX-1602, BOS-47, CCP-070, Cerdulatinib (RVT-502), HuABC-2, Abatacept, Topical Ruxolitinib, VLRX-001) Companies (AXIM Biotechnologies, Incyte Corporation, Bristol-Myers Squibb, Clinuvel Pharmaceuticals), Clinical Study, Growth Drivers, Challenges” provides a complete analysis of global vitiligo drugs market. <br>

renubresearch
Download Presentation

Global Vitiligo Market Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Vitiligo Market

  2. Report Description and Highlights Analyst View: According to Renub Research Global Vitiligo Market will be US$ 2.4 Billion by the year 2024. Growing per capita healthcare expenditure, improving healthcare infrastructure in developing countries, growing diseases awareness and expected approval of Vitiligo drugs are some of the driving force for the growth of this market. India and China are Key Contributors in the Global Vitiligo Patient Population Vitiligo patient’s population is growing across all parts of the world. Patient’s growth rates varies in the countries covered in the report United States, United Kingdom, France, Germany, Italy, India, China and Japan. India and China are key contributors in the global vitiligo patient population. Vitiligo Pipe Line Drugs are Key Strength for this Market Place In the global vitiligo market, vitiligo pipe line drugs will play the major role for the growth of this market. At present several drugs such as ARN-4079, ATI-502, AX-1602, BOS-47, CCP-070, Cerdulatinib (RVT-502), HuABC-2, Abatacept, Topical Ruxolitinib, VLRX-001 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.

  3. At present globally over 21 Million people has suffered from this diseases. It is expected that overall prevalence fall between 1-2 percent of the total population. Although Vitiligo disease can arise at any age, it mostly occurs to young and middle age people.  At present globally over 21 Million people has suffered from this diseases. There are number of drugs manufactures working for Vitiligo drugs development across various parts of the globe such as AXIM Biotechnologies, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences, JN Biosciences, Bristol-Myers Squibb, Incyte Corporation, Clinuvel Pharmaceuticals etc. and their Vitiligo drugs development are in various stages. Key Drugs Development Companies are working in this Market Place Key drugs development companies are working in this market place across various parts of the globe such as AXIM Biotechnologies, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences, JN Biosciences, Bristol-Myers Squibb, Incyte Corporation, Clinuvel Pharmaceuticals etc.  Read more here: https://www.renub.com/global-vitiligo-market-p.php

  4. Global Forecast for Vitiligo Patients Population Share Forecast for Vitiligo Patients Population Share (Percent), 2018 – 2024 Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report

  5. Segments, Countries, Drugs Profile and Companies Covered in this Report • Segments - Global Vitiligo Market •    Vitiligo Patients Population•    Vitiligo Market • Countries - Global Vitiligo Market • • United States • • United Kingdom • • France • • Germany • • Italy • • India • • China • • Japan Global Vitiligo Market – Drugs Profile Covered  • •    ARN-4079•    ATI-502•    AX-1602•    BOS-47•    CCP-070 • •Cerdulatinib (RVT-502) •    HuABC-2 •Abatacept •    Topical Ruxolitinib •    VLRX-001 Want more Information about this market? Request a free sample copy: https://www.renub.com/contactus.php

  6. Global Forecast for Vitiligo Market Share (Percent) Forecast for VitiligoMarket Share (Percent), 2018 – 2024 Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report

  7. Segments covered in this report • Companies Covered • • AXIM Biotechnologies • • Incyte Corporation • • Bristol-Myers Squibb • • ClinuvelPharmaceuticals • Browse Related Report : • Diabetes Drug Market • United States Generic Drugs Market • Contact Us • Tel: +1-678-302-0700 (US), +91-120-421-9822 (INDIA) • Email: info@renub.com

More Related